April 8, 2019 Price forecast | 2 weeks: -0.03% | 1 month: 0.76% | 3 months: 2.68%

SVRA stock forecast

Our latest prediction for Savara, Inc.'s stock price was made on the April 8, 2019 when the stock price was at 9.03$.

In the short term (2weeks), SVRA's stock price should underperform the market by -0.03%. During that period the price should oscillate between -8.22% and +10.57%.

In the medium term (3months), SVRA's stock price should outperform the market by 2.68%. During that period the price should oscillate between -18.79% and +29.33%.

About Savara, Inc.

Savara, Inc. is a clinical-stage specialty pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its products include AeroVanc, Molgradex, GM-CSF, and Aironite. The company was founded on April 27, 2017 and is headquartered in Austin, TX.

At the moment the company doesn't generate any revenue.

On its last earning announcement, the company reported a loss of -1.85$ per share.

The book value per share is 2.36$

Savara, Inc. website

Three months stock forecastApril 8, 2019


Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
- - -48M - -62M -1.85 - - 33M 2.36 -39M - -39M